Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation [Phase 2, Phase 3]

View source ↗

Summary

Mayo Clinic sponsors a clinical trial evaluating vagal nerve stimulation with nicotine replacement therapy for smoking cessation, in Phase 2/3 and not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine replacement therapy (nicotine replacement therapy)
  • Vagal nerve stimulation device

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking Cessation | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING